Presentation is loading. Please wait.

Presentation is loading. Please wait.

Clopidogrel use before renal artery angioplasty with/without stent placement resulted in tertiary procedure risk reduction  Albeir Y. Mousa, MD, Mike.

Similar presentations


Presentation on theme: "Clopidogrel use before renal artery angioplasty with/without stent placement resulted in tertiary procedure risk reduction  Albeir Y. Mousa, MD, Mike."— Presentation transcript:

1 Clopidogrel use before renal artery angioplasty with/without stent placement resulted in tertiary procedure risk reduction  Albeir Y. Mousa, MD, Mike Broce, BA, John Campbell, MD, Aravinda Nanjundappa, MD, Patrick A. Stone, MD, Shadi Abu-Halimah, MD, Mohit Srivastava, MD, Mark C. Bates, MD, Ali F. AbuRahma, MD  Journal of Vascular Surgery  Volume 56, Issue 2, Pages (August 2012) DOI: /j.jvs Copyright © 2012 Society for Vascular Surgery Terms and Conditions

2 Fig 1 Life-table analysis between clopidogrel and acetylsalicylic acid (ASA) for target vessel revascularization (TVR). Cumulative freedom from TVR at 8 years was 93.5% for clopidogrel vs 61% for ASA (P = .51). Error bars >10% not shown. Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © 2012 Society for Vascular Surgery Terms and Conditions

3 Fig 2 Life-table analysis between clopidogrel and acetylsalicylic acid (ASA) for in-stent restenosis (ISR). Cumulative freedom from ISR at 4 years was 27.2% for clopidogrel vs 32.9% for ASA (P = .76). Error bars >10% not shown. Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © 2012 Society for Vascular Surgery Terms and Conditions

4 Fig 3 Life-table analysis between clopidogrel and acetylsalicylic acid (ASA) for estimated glomerular filtration rate (eGFR) < 30. Freedom for low renal function (eGFR < 30 mL/min) was more than 75% at 5 years and no group differences were found. Error bars >10% not shown. Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © 2012 Society for Vascular Surgery Terms and Conditions


Download ppt "Clopidogrel use before renal artery angioplasty with/without stent placement resulted in tertiary procedure risk reduction  Albeir Y. Mousa, MD, Mike."

Similar presentations


Ads by Google